News - solanezumab, Biotechnology

Filter

Current filters:

solanezumabBiotechnology

Popular Filters

Mixed results with Eli Lilly Alzheimer's drug solanezumab, but investors pleased

09-10-2012

US pharma major Eli Lilly (NYSE: LLY) yesterday reported detailed results from two Phase III studies…

BiotechnologyEli LillyNeurologicalPharmaceuticalResearchsolanezumab

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top